Autopsy report · NCT02542202

Stereotactic Body Radiation Therapy in Treating Patients With Metastatic or Recurrent Kidney Cancer

“due to slow enrollment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 4 months after it had already started.
• Ran for about 7 years 11 months before it stopped.
• 25 participants enrolled.
• Results were posted on the registry 1 year 2 months after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

University of Chicago

Sponsor type

University, hospital or other

Conditions

Metastatic Renal Cell Cancer; Recurrent Renal Cell Carcinoma; Stage IV Renal Cell Cancer

Interventions

Stereotactic Body Radiation Therapy

Participants

25

Sites

1

Countries

United States

Trials that died the same way

• Customized Contrast Media Dose Clinical Trial
  “Slow enrollment.” (91% match in meaning)
• EXCimEr Laser for Long lENgTh Lesions in Below-The-Knee Arteries Study
  “too slow enrollment” (90% match in meaning)
• Proton Radiation Therapy for Pituitary Adenoma
  “Due to slow enrollment and feasibility issues.” (90% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.